EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 183 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $434,000 | +65.0% | 9,767 | +83.6% | 0.02% | +60.0% |
| Q1 2022 | $263,000 | -38.7% | 5,319 | -47.0% | 0.01% | -64.3% |
| Q2 2021 | $429,000 | -40.7% | 10,034 | -42.2% | 0.03% | -22.2% |
| Q1 2021 | $724,000 | -7.4% | 17,348 | +3.4% | 0.04% | +5.9% |
| Q4 2020 | $782,000 | -33.6% | 16,784 | -39.4% | 0.03% | -38.2% |
| Q3 2020 | $1,177,000 | +15.3% | 27,718 | +30.2% | 0.06% | +5.8% |
| Q2 2020 | $1,021,000 | -25.5% | 21,284 | -28.5% | 0.05% | -47.5% |
| Q1 2020 | $1,370,000 | +143.8% | 29,785 | +218.2% | 0.10% | +296.0% |
| Q4 2019 | $562,000 | -50.9% | 9,360 | -53.7% | 0.02% | -56.9% |
| Q3 2019 | $1,144,000 | -3.4% | 20,224 | -13.8% | 0.06% | -19.4% |
| Q1 2019 | $1,184,000 | -8.6% | 23,459 | -27.0% | 0.07% | -30.8% |
| Q4 2018 | $1,295,000 | -24.7% | 32,140 | +29.6% | 0.10% | -21.2% |
| Q3 2018 | $1,719,000 | -5.1% | 24,795 | +3.6% | 0.13% | -6.4% |
| Q2 2018 | $1,811,000 | +307.9% | 23,935 | +325.0% | 0.14% | +252.5% |
| Q2 2017 | $444,000 | -42.1% | 5,632 | -41.7% | 0.04% | -51.2% |
| Q4 2016 | $767,000 | – | 9,665 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |